$JNJ plans to separate DePuy Synthes as newer drugs offset Stelara competition. Tickeron examines the portfolio reset, oncology growth and residual talc-litigat

BWB News TV • 2026-11-07 21:01 UTC • By Billy Odell Tucker-Robinson

$JNJ plans to separate DePuy Synthes as newer drugs offset Stelara competition. Tickeron examines the portfolio reset, oncology growth and residual talc-litigation risk. A planned separation is not a completed deal. #healthcare

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly